Siemens Healthineers (OTCMKTS:SMMNY) Issues Earnings Results

Siemens Healthineers (OTCMKTS:SMMNY) released its quarterly earnings results on Thursday. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.02, Zacks reports. The firm had revenue of $6.68 billion for the quarter, compared to analyst estimates of $6.96 billion.

Siemens Healthineers Stock Down 0.4%

OTCMKTS:SMMNY traded down $0.07 during trading hours on Friday, reaching $19.84. 147,758 shares of the stock were exchanged, compared to its average volume of 169,811. Siemens Healthineers has a twelve month low of $19.54 and a twelve month high of $28.92. The business has a 50-day moving average of $21.90 and a two-hundred day moving average of $24.41.

Analysts Set New Price Targets

A number of research firms have commented on SMMNY. Zacks Research upgraded Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Monday, January 12th. Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research note on Friday, January 23rd. Finally, Sanford C. Bernstein upgraded Siemens Healthineers to a “strong-buy” rating in a research note on Tuesday, January 13th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Siemens Healthineers presently has a consensus rating of “Buy”.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.